Indaptus Therapeutics, Inc. — Form 8-K
Filed September 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Indaptus extended the 'Outside Date' for a stock purchase agreement from September 29, 2026 to October 16, 2026, allowing purchasers to defer closing and funding deadlines by 17 days. The company may retain any subscription amounts received before closing and will not breach by delaying share issuance. No dollar amounts, share counts, or purchaser names are specified in this form notice.
Why this rating
Administrative extension of equity financing closing; no material terms disclosed. Procedural delay suggests execution challenges but preserves ongoing transaction structure.
See more from September 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.